logo
Plus   Neg
Share
Email

Uniper Turns To Profit In 2019

German energy generation and energy trading company Uniper SE, a subsidiary of E.ON SE (EONGY.PK), reported that its net income attributable to shareholders for fiscal year 2019 was 610 million euros or 1.67 euros per share, compared to a net loss of 401 million euros or 1.10 euros per share in the prior year.

The year-on-year increase was principally attributable to positive effects resulting from the marking to market of commodity derivatives at the balance-sheet date.

Annual sales declined to 65.80 billion euros from 91.81 billion euros in the prior year.

The company intends to make its power generation portfolio in Europe climate-neutral by 2035.

The company will therefore propose to the Annual Shareholders Meeting on May 20 that a total dividend of 421 million euros be paid for the 2019 fiscal year, an increase of 28 percent compared with the previous year.

Between now and 2022, Uniper will invest more than 1.2 billion euros in projects that accelerate the transition to a lower-carbon energy world.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT